Antivirals like nirmatrelvir and molnupiravi and the most recent COVID-19 vaccines both “significantly lowered the likelihood of hospitalization and death from currently circulating COVID-19 variants,” in the study that included 27,000 patients who tested positive for COVID-19, according to a March 6 news release.
The antivirals reduced the risk of severe infection by 42%.
Despite the protection offered by COVID-19 vaccines, few U.S. adults have taken advantage of them, with only 17% having received the latest round, according to CDC data.
Even still, on Feb. 28, CDC Director Mandy Cohen, MD, approved the vaccine advisory panel’s motion to move forward with recommending a spring booster for adults over 65 and at-risk individuals.
Dr. Cohen also said March 4 that an updated COVID-19 vaccination is expected in fall 2024 along with the next flu vaccine.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
